CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $313,000 | – | 2,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |